Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

RLS Global

Mindre end 1K følgere
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse20.11.2023, 07.55

RLS Global AB: RLS Global ansöker om konkurs

RLS Global
Selskabsmeddelelse9.11.2023, 21.15

RLS Global AB: RLS Global initiates strategic review process aiming to commercialize ChloraSolv

RLS Global
Selskabsmeddelelse9.11.2023, 21.00

RLS Global AB: RLS Global and Convatec have agreed to terminate collaboration agreement

RLS Global

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Pressemeddelelse6.9.2023, 07.00

RLS Global AB: First patient included in new clinical investigation on pressure ulcers

RLS Global
Pressemeddelelse1.9.2023, 11.00

RLS Global AB: ChloraSolv recommended for UK CA certification required for UK market after Brexit

RLS Global
Pressemeddelelse28.8.2023, 05.57

Redeye: RLS Global Q2 2023 - Uncertain future

RLS Global
Selskabsmeddelelse25.8.2023, 07.00

RLS Global AB: RLS GLOBAL AB (publ) PUBLISHES INTERIM REPORT FOR THE PERIOD APRIL-JUNE 2023

RLS Global
Selskabsmeddelelse24.8.2023, 16.30

RLS Global AB: RLS GLOBAL AB (PUBL) RAISES A SHORT-TERM LOAN OF MSEK 5.0

RLS Global
Selskabsmeddelelse22.8.2023, 13.00

RLS Global AB: RLS Global appoints Torbjörn Sannerstedt as new Chief Financial Officer

RLS Global
Pressemeddelelse1.6.2023, 10.55

Redeye: RLS Global Q1 2023: Delay in Europe but progress in the Middle East

RLS Global
Selskabsmeddelelse31.5.2023, 06.30

RLS Global AB (publ) Interim Report, Q1, 2023

RLS Global
Pressemeddelelse20.3.2023, 10.00

RLS Global AB: ChloraSolv shows notably greater antibiofilm activity in vitro compared to other debridement products in published article

RLS Global
Pressemeddelelse1.3.2023, 13.48

Redeye: RLS Global Q4 2022 - No surprises – but expectations of an eventful 2023

RLS Global
Selskabsmeddelelse28.2.2023, 07.30

RLS Global AB (publ) Year-end Report, Q4, 2022

RLS Global
Selskabsmeddelelse24.1.2023, 20.40

Lars Johansson nominated as new Chairman of the Board of RLS Global AB

RLS Global
Pressemeddelelse9.12.2022, 08.00

RLS Global AB: RLS Global: The rights issue is registered and the trading in Paid Subscription Shares ceases

RLS Global
Selskabsmeddelelse24.11.2022, 07.00

RLS Global AB (publ) Interim Report, Q3, 2022

RLS Global
Selskabsmeddelelse14.11.2022, 21.45

RLS Global AB: RLS Global: Outcome in RLS Global's rights issue

RLS Global
Pressemeddelelse10.11.2022, 10.00

Presentation by Björn Larsson, CEO, RLS Global AB, about the company's operations and the currently ongoing rights issue

RLS Global
Pressemeddelelse4.11.2022, 13.30

RLS Global AB: RLS Global's CEO Björn Larsson interviewed by Erik Penser Bank about the ongoing rights issue

RLS Global
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.